Urinary excretion of biomarkers of oxidatively damaged DNA and RNA in hereditary hemochromatosis.
about
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examplesFree radicals: properties, sources, targets, and their implication in various diseasesPersonalized medicine in human space flight: using Omics based analyses to develop individualized countermeasures that enhance astronaut safety and performanceEuropean contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).The biological and metabolic fates of endogenous DNA damage productsOxidative damage to RNA: mechanisms, consequences, and diseases.Independent generation and reactivity of uridin-2'-yl radicalInsights into the pathogenesis and treatment of cancer from inborn errors of metabolism.Genetic and environmental influences on oxidative damage assessed in elderly Danish twins.Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD.Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates.Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron)Characterization of RNA damage under oxidative stress in Escherichia coli.Paraoxonase-1 status in patients with hereditary hemochromatosisMarkers of oxidant stress that are clinically relevant in aging and age-related diseaseTotal mortality by elevated transferrin saturation in patients with diabetesIncreased DNA and RNA damage by oxidation in patients with bipolar I disorderThe association between low-grade inflammation, iron status and nucleic acid oxidation in the elderly.Assays for urinary biomarkers of oxidatively damaged nucleic acids.Oxidative damage to RNA in aging and neurodegenerative disorders.The effect of empagliflozin on oxidative nucleic acid modifications in patients with type 2 diabetes: protocol for a randomised, double-blinded, placebo-controlled trial.Mechanisms of DNA damage, repair, and mutagenesis.Increased iron stores prolong the QT interval - a general population study including 20 261 individuals and meta-analysis of thalassaemia major.Biophysical properties, thermal stability and functional impact of 8-oxo-7,8-dihydroguanine on oligonucleotides of RNA-a study of duplex, hairpins and the aptamer for preQ1 as models.Simvastatin and oxidative stress in humans: A randomized, double-blinded, placebo-controlled clinical trial.Clarithromycin, trimethoprim, and penicillin and oxidative nucleic acid modifications in humans: randomised, controlled trials.Blood removal therapy in hereditary hemochromatosis induces a stress response resulting in improved genome integrity.Tobacco smoking and oxidative stress to DNA: a meta-analysis of studies using chromatographic and immunological methods.The Ratio of Plasma and Urinary 8-oxo-Gsn Could Be a Novel Evaluation Index for Patients with Chronic Kidney Disease.Fasting serum levels of ferritin are associated with impaired pancreatic beta cell function and decreased insulin sensitivity: a population-based study.Markers of oxidative stress in obese men with and without hypertension.Levels of 8-oxo-dGsn and 8-oxo-Gsn in random urine are consistent with 24 h urine in healthy subjects and patients with renal disease.Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells
P2860
Q24289511-F2B797CF-92D1-4716-84CB-536DEBD0BAAFQ27000071-39100EC9-AED6-408C-9933-F156F9B8763EQ28661646-7C7BBB19-18B8-4A32-9CD6-3E92107CE330Q33761211-B455C0A6-8090-4CEA-96C0-FDFEDE2D084DQ34157752-26BDCDB0-5F1C-4214-A02C-C5074E5990FBQ34441389-DDEF1E7F-A591-4609-B925-7919A9286D92Q34488715-26E451EA-303E-40E0-A0E9-6488E7F019B6Q34768395-956468AD-0229-48E1-A477-B33B320CDAC8Q34959146-778650D2-ADC5-40C6-AF4E-2358D50C7C71Q35857178-99B92E8B-D6A5-4A7F-82F5-862BECB68ED6Q35906815-18C2287E-9949-4B52-828E-F4AFFE41A12CQ35960098-81085163-DC94-4C83-A354-2F1E05616F13Q36114529-3998D583-E686-4797-87D1-C5B5B4CAF648Q36754854-0D9D6C5F-C499-4E86-972F-CD86C5EA50ADQ36879018-1042387F-A7C3-407F-99AA-E6A5FC7ABA46Q37106394-FF05D8EE-266F-42F9-B166-91091276AE6EQ37254546-7812EA33-47F6-420D-96CF-62308936861AQ37361573-01E881CF-E46C-44B4-81B5-EA6680D77896Q37986872-E97D7206-E62C-4C82-A11D-BE7FDE86E0AFQ38016374-1688912E-7A03-49E1-BD37-9D5142C82C11Q38793748-D2D41D9F-29DE-48EE-80C8-88FB9C862362Q39293345-8596A6E9-05B9-4ECE-B596-C928BACCFEFFQ40808732-330F0CB4-2E4B-4A7A-96D2-7FD3735D107AQ42291807-58B1F2F0-B2FF-49B1-AA9E-B15B6B7BC2A6Q42725614-53ADBC61-F826-4427-ACA0-57500F8E3319Q46420088-FF35721B-0D46-4914-B04E-51DCC6391552Q47321089-C90E184F-F518-48A7-B14E-1B7C1332A4BAQ50546223-1B5177CD-9508-402D-8ED1-5CA97725B9DFQ51244470-46700319-A373-4EAA-8A7B-05512260D1A3Q51311015-63F7285A-29E5-44F6-B4D4-6B10455915C1Q53570517-85A247C4-C82C-467D-949F-0DFDD19400DCQ54754781-7A954501-2090-40BC-BC36-387123AFE492Q56974269-9D089458-5389-44F9-9B66-6B80D3EAE7F1
P2860
Urinary excretion of biomarkers of oxidatively damaged DNA and RNA in hereditary hemochromatosis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Urinary excretion of biomarker ...... in hereditary hemochromatosis.
@en
Urinary excretion of biomarker ...... in hereditary hemochromatosis.
@nl
type
label
Urinary excretion of biomarker ...... in hereditary hemochromatosis.
@en
Urinary excretion of biomarker ...... in hereditary hemochromatosis.
@nl
prefLabel
Urinary excretion of biomarker ...... in hereditary hemochromatosis.
@en
Urinary excretion of biomarker ...... in hereditary hemochromatosis.
@nl
P2093
P1476
Urinary excretion of biomarker ...... in hereditary hemochromatosis.
@en
P2093
Allan Weimann
Edzard Schwedhelm
Ghainsom D Kom
Kasper Broedbaek
Peter Nielsen
Rainer H Böger
P304
P356
10.1016/J.FREERADBIOMED.2009.08.004
P577
2009-08-14T00:00:00Z